Supernatants from rat peritoneal macrophage cultures stimulated with b
acterial products contain a M(r) 36,000 factor that protects immature
cortical thymocytes from loss of viability over a 4-hr incubation peri
od in vitro. This effect could not be produced with purified transform
ing growth factor-beta or recombinant interleukin-6 (IL-6). Further, t
he partially purified M(r) 36,000 fraction was inactive in bioassays f
or IL-1 and tumour necrosis factor. Maximal production of the factor o
ccurred 2 hr after the addition of 20 mug/ml of lipopolysaccharide, as
assessed by the titre resulting in 100% protection of thymocytes in a
viability assay. The detection of protective activity within 5 min af
ter addition of the stimulant could be attributed to the release of in
tracellular stores but protein synthesis was required to account for t
he increasing titre up to peak levels. The titre fell rapidly after 2
hr so that activity could not be detected at 4 hr. This profile of rel
ease was refractory to repeated stimulation with lipopolysaccharide. C
onjoint addition of lipopolysaccharide and indomethacin, did, however,
allow release in response to subsequent challenge. Related to this fi
nding, prostaglandin E2 completely inhibited the release of protective
activity.